September 17, 2015
FDA Expands use of Novartis’ Promacta® to Include Treatment of Children with Chronic Immune Thrombocytopenia
Read More
June 16, 2015
Kids (Six and Under) With Rare Blood Disorder, Chronic ITP, Get FDA Approval on New Novartis Drug, Promacta
Read More
X